...
首页> 外文期刊>International Journal of Polymer Science >Identification of a Novel Anticancer Oligopeptide from Perilla frutescens (L.) Britt. and Its Enhanced Anticancer Effect by Targeted Nanoparticles In Vitro
【24h】

Identification of a Novel Anticancer Oligopeptide from Perilla frutescens (L.) Britt. and Its Enhanced Anticancer Effect by Targeted Nanoparticles In Vitro

机译:从紫苏(L.)Britt的新型抗癌寡肽的鉴定。靶向纳米粒子的体外合成及其增强的抗癌作用

获取原文

摘要

Objective. Perilla frutescens (L.) Brittis is a dietary herbal medicine and has anticancer effect. However, little is known about its anticancer peptides. This study is aimed at identifying cytotoxic oligopeptides which are loaded by a drug delivery system, to explore its anticancer application. Methods. The oligopeptides were isolated from enzymatic hydrolysates of Perilla seed crude protein by using ultrafiltration, gel filtration chromatography, and reversed-phase high-performance liquid chromatography (RP-HPLC). The structure of the oligopeptide was determined using a peptide sequencer, and its anticancer effect was examined by the MTT assay. PSO (Perilla seed oligopeptide), the most potent anticancer oligopeptide, was loaded by chitosan nanoparticles (NPs) modified by hyaluronic acid (HA). Then, the particle size, zeta potential, encapsulation efficiency (EE), drug loading efficiency (LE), the cumulative release rates of NPs, and its cytotoxic effect on cancer cells were investigated. Results. Three fractions were isolated by the chromatography assay. The third fraction has a broad-spectrum and the strongest anticancer effect. This fraction was further purified and identified as SGPVGLW with a molecular weight of 715 Da and named as PSO. Then, PSO was loaded by HA-conjugated chitosan to prepare HA/PSO/C NPs, which had a uniform size of 216.7 nm, a zeta potential of 35.4 mV, an EE of 38.7%, and an LE of 24.3%. HA/PSO/C NPs had a slow release rate in vitro, with cumulative release reaching to 81.1%. Compared with free PSO, HA/PSO/C NPs showed notably enhanced cytotoxicity and had the strongest potency to human glioma cell line U251. Conclusion. This study demonstrated that PSO, a novel oligopeptide from Perilla seeds, has a broad-spectrum anticancer effect and could be encapsulated by NPs, which enhanced tumor targeting cytotoxicity with obvious controlled release. Our study indicates that Perilla seeds are valuable for anticancer peptide development.
机译:目的。紫苏(B.tis)是一种饮食草药,具有抗癌作用。但是,对其抗癌肽知之甚少。这项研究旨在鉴定药物输送系统负载的细胞毒性寡肽,以探索其抗癌应用。方法。通过使用超滤,凝胶过滤色谱和反相高效液相色谱(RP-HPLC),从紫苏种子粗蛋白的酶水解物中分离出寡肽。使用肽测序仪确定寡肽的结构,并通过MTT测定法检查其抗癌作用。 PSO(紫苏种子寡肽)是最有效的抗癌寡肽,由透明质酸(HA)修饰的壳聚糖纳米颗粒(NP)负载。然后,研究了粒径,ζ电势,包封率(EE),载药率(LE),NP的累积释放速率及其对癌细胞的细胞毒性作用。结果。通过色谱分析分离出三部分。第三部分具有广谱和最强的抗癌作用。进一步纯化该级分,鉴定为分子量为715 Da的SGPVGLW,命名为PSO。然后,通过HA共轭壳聚糖负载PSO以制备HA / PSO / C NP,其平均大小为216.7 nm,ζ电位为35.4 mV,EE为38.7%,LE为24.3%。 HA / PSO / C NPs的体外释放速度较慢,累积释放率达到81.1%。与游离PSO相比,HA / PSO / C NPs具有明显增强的细胞毒性,并且对人脑胶质瘤细胞U251的效力最强。结论。这项研究表明,PSO是一种来自紫苏种子的新型寡肽,具有广谱抗癌作用,并且可以被NP包裹,从而增强了靶向肿瘤的细胞毒性并具有明显的控释作用。我们的研究表明,紫苏种子对于开发抗癌肽很有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号